Pharos Ibio

Provider of therapeutics for oncology and rare disease

placeAnyang, Gyeonggi Do, South Korea calendar_todayFounded 2016 groups22 employees language pharosibio.com

Innovation

12 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 169 times.

YearFilings
20201
20214
20224
20237
20245
20254
20263

Investor mix

12 investors on record.

Investor typeCountShare
Venture capital542%
Private equity217%
Bank & private debt217%
Other / undisclosed325%
Coming soon